『Prostate Cancer Update』のカバーアート

Prostate Cancer Update

Prostate Cancer Update

著者: Dr. Neil Love
無料で聴く

Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing urologists and radiation oncologists ongoing access to the perspectives and opinions of national and international prostate cancer research leaders.Copyright 2025 Research To Practice. All Rights Reserved 科学 衛生・健康的な生活 身体的病い・疾患
エピソード
  • Prostate Cancer — The Optimal Use of Hormonal Therapy
    2026/09/08

    Featuring perspectives from Dr William K Oh and Dr Mary-Ellen Taplin, including the following topics:

    • Introduction: Another Perspective on the Treatment of Localized Prostate Cancer (0:00)
    • Nonmetastatic Disease (10:32)
    • Metastatic Androgen Pathway Modulation-Naïve and Androgen Pathway Modulation-Sensitive Disease (41:50)

    CME information and select publications

    続きを読む 一部表示
    59 分
  • AKT Inhibition in Prostate Cancer — Microlearning Activity 3: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium
    2026/09/05

    Featuring perspectives from Dr Karim Fizazi, Dr Daniel George and Dr Elisabeth I Heath, moderated by Dr Heath, including the following topics:

    • Tolerability of capivasertib and management of associated side effects — Question from Neeraj Agarwal, MD, FASCO (0:00)
    • Case: A man in his early 70s with Type 2 diabetes presents with metastatic hormone-sensitive prostate cancer with widespread bone metastases and PTEN deficiency on next-generation sequencing and receives relugolix/darolutamide — Rana R McKay, MD, FASCO (8:39)

    CME information and select publications

    続きを読む 一部表示
    18 分
  • For Oncology Nurses: Prostate Cancer — Proceedings from the 2026 Annual ONS Congress
    2026/08/31

    Featuring perspectives from Mr Michael Lai, Dr Scott T Tagawa, Ms Stacy E Walker and Dr Evan Y Yu, moderated by Dr Tagawa, including the following topics:

    • Introduction (0:00)
    • Overview of Prostate Cancer (3:00)
    • Hormonal Therapy for Nonmetastatic and Metastatic Hormone-Sensitive Prostate Cancer (HSPC) (6:12)
    • Potential Role of Capivasertib in Metastatic HSPC (27:22)
    • Current and Potential Future Role of PARP Inhibitors in Metastatic PC (46:39)
    • Current and Future Role of Lutetium Lu 177 Vipivotide Tetraxetan for Patients with Metastatic PC (1:09:14)

    CME information and select publications

    続きを読む 一部表示
    1 時間 28 分
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません